Literature DB >> 33718623

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI.

Frank Broekmans1, Peter Humaidan2, George Lainas3, Mira Töyli4, Nathalie Le Clef5, Nathalie Vermeulen5.   

Abstract

Entities:  

Year:  2021        PMID： 33718623      PMCID： PMC7938347          DOI： 10.1093/hropen/hoab006

Source DB:  PubMed          Journal:  Hum Reprod Open        ISSN： 2399-3529


× No keyword cloud information.
  8 in total

1.  The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early Pregnancy.

Authors:  Mahmoud Zaqout; Emad Aslem; Mazen Abuqamar; Osama Abughazza; Joseph Panzer; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2015-05-15       Impact factor: 1.655

Review 2.  Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.

Authors:  Gabriele Saccone; Corina Schoen; Jason M Franasiak; Richard T Scott; Vincenzo Berghella
Journal:  Fertil Steril       Date:  2016-11-22       Impact factor: 7.329

3.  Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.

Authors:  Ravichandran Nadarajah; Hemashree Rajesh; Ker Yi Wong; Fazlin Faisal; Su Ling Yu
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

4.  A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Authors:  Herman Tournaye; Gennady T Sukhikh; Elke Kahler; Georg Griesinger
Journal:  Hum Reprod       Date:  2017-05-01       Impact factor: 6.918

5.  Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI.

Authors:  Paul C M Piette
Journal:  Hum Reprod Open       Date:  2021-03-03

Review 6.  Fetal safety of medications used in treating infertility.

Authors:  Gideon Koren; Yael Barer; Yusuf Cem Kaplan
Journal:  Expert Rev Clin Pharmacol       Date:  2020-10-03       Impact factor: 5.045

Review 7.  A systematic review of dydrogesterone for the treatment of threatened miscarriage.

Authors:  Howard Carp
Journal:  Gynecol Endocrinol       Date:  2012-07-16       Impact factor: 2.260

8.  Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.

Authors:  Georg Griesinger; Christophe Blockeel; Gennady T Sukhikh; Ameet Patki; Bharati Dhorepatil; Dong-Zi Yang; Zi-Jiang Chen; Elke Kahler; Claire Pexman-Fieth; Herman Tournaye
Journal:  Hum Reprod       Date:  2018-12-01       Impact factor: 6.918
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.